Clinical Trials

EMBOLD: Phase 1b/2 Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Previously Treated Unresectable Advanced or Metastatic Sarcomas

Link : https://www.clinicaltrials.gov/ct2/show/NCT07602777
Status : RECRUITING
Population : Previously treated osteosarcoma and STS (LMS, LPS, and other STS)
Description : ADC with topoisomerase I inhibitor payload, targeting B7-H3.
PI : A. Razak
Centers Opened : PMH
Phase : Ib/II
IIST/Pharma : Pharma